I noticed that BOC - what i also found interesting was the lifting of ratings from two parties after the WI Perth conference - Wholesale Investor officialy commenced coverage of Phylogica & now rank PYC as "Mature Stage" & Bioshares lifted it from Speculative Class B buy to Speculative Class A. You would have to think they both had a little one to one after the presentation.
I think Roche entering the next stage & re-structuring the deal is going to be a CRACKER - Bioshares have called it one of his years highlights already. Obviously this is the point where each deal goes from being a simple screening to locate & provide suitable candidates to actually applying these candidates to the next levl. Roche will set a precedent for what to expect in the future from new & existing deals imo.
I just can't wait to get this freakin GM done & dusted.
PYC Price at posting:
6.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)